Related references
Note: Only part of the references are listed.Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma
Deborah R. Smith et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Emerging functions of the EGFR in cancer
Sara Sigismund et al.
MOLECULAR ONCOLOGY (2018)
Treatment-associated TP53 DNA-binding domain missense mutations in the pathogenesis of secondary gliosarcoma
Margaret Pain et al.
ONCOTARGET (2018)
Tumorigenicity of Ewing sarcoma is critically dependent on the trithorax proteins MLL1 and menin
Laurie K. Svoboda et al.
ONCOTARGET (2017)
NF-κB Signalling in Glioblastoma
Vincent Soubannier et al.
BIOMEDICINES (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients
Guobin Zhang et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide
Ralf S. Schmid et al.
NEURO-ONCOLOGY (2016)
Epidermal growth factor receptor (EGFR) gene amplification in high-grade gliomas: Western Indian tertiary cancer center experience
Divya Shelly et al.
NEUROLOGY INDIA (2016)
Targeting NF-kappa B in glioblastoma: A therapeutic approach
Dinorah Friedmann-Morvinski et al.
SCIENCE ADVANCES (2016)
Glioblastoma: pathology, molecular mechanisms and markers
Kenneth Aldape et al.
ACTA NEUROPATHOLOGICA (2015)
Interactive analysis of large cancer copy number studies with Copy Number Explorer
Scott Newman
BIOINFORMATICS (2015)
Primary and secondary gliosarcomas: clinical, molecular and survival characteristics
David Cachia et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme
Sadaharu Tabuchi
LIPIDS IN HEALTH AND DISEASE (2015)
OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy
Ichiyo Shibahara et al.
MOLECULAR CANCER (2015)
Current therapeutic advances targeting EGFR and EGFRvIII in glioblastoma
Emily Padfield et al.
FRONTIERS IN ONCOLOGY (2015)
The Somatic Genomic Landscape of Glioblastoma (Vol 155, pg 462, 2013)
Cameron W. Brennan et al.
CELL (2014)
Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs
Laurie K. Svoboda et al.
EPIGENETICS (2014)
HOX genes and their role in the development of human cancers
Seema Bhatlekar et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Implications of Rho GTPase signaling in glioma cell invasion and tumor progression
Shannon Patricia Fortin Ensign et al.
FRONTIERS IN ONCOLOGY (2013)
Reply: EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?
A. Algars et al.
BRITISH JOURNAL OF CANCER (2012)
Chemokine Receptor Requirements for Epidermal T-Cell Trafficking
Noah J. Tubo et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
The prognostic impact of O6-methylguanine DNA methyltransferase and epidermal growth factor receptor expressions on primary gliosarcoma: A clinicopathologic and immunohistochemical study of seven cases at a single institution
Jui-Wei Lin et al.
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY (2011)
The Pathobiology of Glioma Tumors
Candece L. Gladson et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity
Seunggu J. Han et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma
Rajeev Vibhakar et al.
NEURO-ONCOLOGY (2007)
Characterization of glioblastomas in young adults
B. K. Kleinschmidt-DeMasters et al.
BRAIN PATHOLOGY (2006)
Predominant expression of mutant EGFR (EGFRvIII) is rare in primary glioblastomas
W Biernat et al.
BRAIN PATHOLOGY (2004)
Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components
B Actor et al.
GENES CHROMOSOMES & CANCER (2002)
Share Paper
